NANOVIRICIDES, INC. cotiza a 1.32 USD y tiene una capitalización bursátil de $34M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
NanoViricides, Inc., a clinical stage nano-biopharmaceutical company, discovers, develops, and commercializes drugs to combat viral infections. The company's product portfolio includes NV-387 drug candidate developed for RSV and influenza indications and has completed phase 1a/1b human clinical trial for the evaluation…
| Periodo | 2026-09 | 2026-05 | 2026-02 | 2025-11 |
|---|---|---|---|---|
| Real | $-0.10 | $-0.09 | $-0.11 | $-0.10 |
| Estimado | $-0.09 | $-0.08 | $-0.08 | $-0.18 |
| Sorpresa | -11.1% | -12.5% | -37.5% | +44.4% |
| Métrica | NNVC | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -94.7% | -40.4% | -54.3% |
| ROA | -83.2% | -32.0% | -51.2% |
| Current Ratio | 2.66 | 2.84 | -0.18 |
| Debt / Equity | — | 0.28 | — |